To extravasate from the blood stream and enter the tumor site, (CAR) T cells sense chemokine gradients including CXCL9, CXCL10 or CXCL11, which are released by tumor-related stromal and endothelial cells and presented on the endothelial surface. The gene discussed is CXCL9; the disease is neoplasm.